Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Golden Meditech Holdings Limited Announces 2011/ 2012 Annual Results

      Revenue from Core Businesses Increased by 32.1%

      Healthcare Services Segment as Growth Engine with 84% Increase in Revenue and Accounted for 34% of the Group's Total Revenue

      Resumed Payment of Dividend at HK 1.0 cent Per Share


      News provided by

      Golden Meditech Holdings Limited

      Jun 27, 2012, 05:31 ET

      Share this article

      Share this article


      HONG KONG, June 27, 2012 /PRNewswire-Asia/ --

      Financial Highlights




      HK$ '000

      For the year

      ended 31 March 2012

      For the year

      ended 31 March 2011

      Change

      +/-

      Revenue

      433,222

      328,066

      32.1%

      - Hospital Management Service Income

      147,110

      80,412

      82.9%

      - Medical Insurance Administration Service Income

      811

      -

      N/A

      - Medical Devices Sales

      153,603

      148,581

      3.4%

      - Medical Accessories Sales

      104,209

      96,170

      8.4%

      - Chinese Herbal Medicine Sales

      27,489

      2,903

      846.9%

      Share of Profit from Associates

      169,576

      122,939

      37.9%

      - China Cord Blood Corporation (CCBC, CO:US)

      63,683

      41,720

      52.6%

      - China National Medical Equipment Co., Ltd (CMIC)

      11,384

      7,408

      53.7%

      - Fortress Group Limited (A SPV for Privatized FunTalk China in August 2011)

      94,509

      73,811

      28.0%

      Profit After Tax

      171,306

      359,234

      -52.3%

      Adjusted Profit Attributable to Shareholders*

      237,400

      210,412

      12.8%

      Profit Attributable to Shareholders

      152,877

      343,208

      -55.5%

      Adjusted Earnings Per Share (Basic)*

      12.0cents

      12.2cents

      -1.6%

      Earnings Per Share (Basic)

      7.7cents

      19.9 cents

      -61.3%

      * Excluding impact from the fair value change of financial liabilities and financial assets





      Golden Meditech Holdings Limited ("Golden Meditech," together with its subsidiaries collectively as the "Group," - 801.HK; 910801.TW), a leading integrated healthcare enterprise in China, is pleased to announce the Group's annual results for the year ended 31 March 2012 ("Fiscal Year"). During the year under review, the Group continued to report growth in revenues from its two core business segments, namely healthcare services business and medical devices business. Total revenue for the Fiscal Year rose by 32% to HK$433,222,000. While excluding non-cash impacts from the fair value change of financial liabilities and financial assets, profits after taxes for the period, which included contributions from its affiliates, China Cord Blood Corporation and FunTalk China Holdings Limited, grew by 12.8% relative to the previous year as these two associates together contributed HK$158,192,000 in profits to the Group.  Profit attributable to shareholders for the year decreased by 55.5% to HK$152,877,000, if the abovementioned non-cash effect is included.

      Commenting on the annual results, Mr. Kam Yuen, Chairman and Chief Executive Officer of the Group, said, "Despite volatility amidst the global economy during the year, the Group reported growth in revenues from each business segment, leveraging its industry leading position and unparalleled execution skill. Revenues from our healthcare services business and medical devices business accounted for 34% and 60% of total revenue, respectively. The revenue mix has been enhanced and the Group has been evolving from a single-business company, focusing on medical devices business, into a leading integrated healthcare enterprise in China, with two major business segments that are complementary and supplementary to each other. At the same time, we have introduced New Horizon Capital, a China-focused institutional investor, to become a strategic shareholder of the Group to strengthen our shareholder base. With its extensive China-specific experience and industry knowledge, we believe the introduction is a sound move that will benefit the Group in achieving its long-term goals.

      During the year, the Group bought back about HK$48,619,000 worth of the Company's shares from open market. If inclusive of a final dividend of HK one cent per share proposed by the Board of Directors, the payout to shareholders is equivalent to HK3.4 cents per share or 40% of the Group's annual operating profit.

      Healthcare Services Segment

      Revenues from the healthcare services segment grew by 84% on a year-to-year basis to HK$147,921,000.  This segment includes the two renowned Daopei hematology hospitals in Beijing and Shanghai and Shanghai East International Medical Center (SEIMC). The stable performance of the hematology hospitals is in-line with the Group's expectations.  SEIMC also made significant contributions to the Group's revenue since August 2011.  

      In June 2011, the Group announced the successful acquisition of a new hospital facility in Beijing's Haidian District, which consists of a partially completed hospital facility with a site area of approximately 18,692 sqm and permissible construction area of 74,035 sqm. This site will have a 500-bed capacity after completion, five times the current capacity of Daopei hospital in Beijing. Construction of the new hospital is well underway and is expected to be completed by the end of 2012. The Group thus intends to relocate Beijing Daopei Hospital's existing operation from its current location to the new, expanded premise in Haidian District. The new hospital will be a top-notched hospital that is set to provide hematology services in addition to other discipline and outpatient facilities that will cater to its surrounding neighborhoods.  

      During the year under review, the Group also made substantial progress in its medical insurance administration business process outsourcing (BPO) joint venture, GM Medicare Co., Ltd. This segment, consisting of providing administration outsourcing services for medical insurance companies and claim processing services for hospitals, has commenced trial operation during this year.  

      China Cord Blood Corporation, the Group's associate company, has reported RMB380,490,000 in revenue during the Fiscal Year ended March 31, 2012 compared to RMB339,532,000 for the previous fiscal year, equivalent to 12% growth.  Total number of subscribers grew up to 239,754, up 29% from the previous year.  The Group increased its shareholding in China Cord Blood Corporation and currently owns 41.4% of its shares. CCBC contributed HK$63,683,000 to the Group's profits during the year under review.

      Medical Devices Segment

      With the introduction of a number of policies, such as the "Level III General Hospital Accreditation and Administration Standards" that helps promote more clinical usage of autologous blood recovery devices, the medical devices segment will benefit from a favourable regulatory environment in the future. Higher clinical utilization for devices led to 8.4% year-on-year growth in revenue from medical accessories sales, referring to the exclusive consumables for the Group's medical devices. Medical devices sales also grew by 3.4% year-on-year as the Group's products continue to secure its market share amongst top-tier hospitals.  

      China National Medical Equipment Co., Ltd (CMIC), an associate company of the Group and the affiliate company of Sinopharm Group Co. Ltd., is one of the leading medical device distributors in China. The Group currently own 17.5% stake in CMIC as its second largest shareholder. CMIC contributed HK$11,384,000 to the Group's profits as an associate company during the review period.

      Strategic Investments

      The Group's strategic investments currently include 29.4% stake in Fortress Group Limited (Fortress), which owns the privatized FunTalk China after its delisting from NASDAQ and a Chinese herbal business.  The Chinese herbal medicine business consists of a GMP-approved production facility over a site area of 58,000 sqm ideally located in a prime location in Municipal Shanghai. Fortress contributed HK$94,509,000 to the Group with 28% increase relative to the previous year.  

      Outlook and Strategies

      Looking ahead, Mr. Kam commented, "The Group adheres to the view that the future outlook of China's healthcare industry will remain positive. The Group will continue to focus on the healthcare industry while building on its integrated healthcare business platform in China.  The new site for the expanded Daopei Hospital in Beijing will be another growth catalyst to this segment.  We believe the opening of the new Beijing hospital will be instrumental in cementing the Group's market position in the rapidly growing private hospital market in China, and will expand our operations in the hospital market and strengthen its brand name and revenue base. Hence, we will continue to progressively yet prudently explore further expansion opportunities in the hospital management market. In addition, we also see that the Group's medical devices segment will further benefit from a favourable policy environment that is supportive to alternative solutions to allogeneic blood transfusion.  We believe our product penetration into lower-tiered hospitals and the improvement in utilization will be beneficial to our medical device segment in the long run."

      About Golden Meditech Holdings Limited

      Golden Meditech Holdings Limited is China's leading integrated-healthcare enterprise. Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities. Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

      SOURCE Golden Meditech Holdings Limited

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.